Page 137 - Aet News Today

Adonis, a startup offering a revenue cycle automation platform purpose-built for healthcare, recently closed a Series A funding round led by General Catalyst. The company has raised nearly $23 million to date since launching last year.

Included Health and DispatchHealth are partnering to combine Included's virtual care services with DispatchHealth's home care services. If an Included physician notices a patient requires in-person support, the physician will send DispatchHealth to the patient's home.

Bausch + Lomb drug Miebo is now FDA approved as a new treatment for dry eye disease. Unlike many products that rewet the eye, Miebo is designed to address one of the factors that leads to dry eyes.

A group of labor unions have filed an antitrust complaint against UPMC. They alleged that the health system has prevented its workers from being able to advocate for themselves and their patients through “a draconian system of mobility restrictions and widespread labor law violations that lock in sub-competitive pay and working conditions.”

Companies presenting their technology at the conference seek to support a diverse patient population spanning conditions such as inflammatory bowel disease, food allergies, and cancer. Cell, gene therapy and immunotherapies also form some of their treatment approaches in development.

Lucem Health recently closed a $7.7 million Series A funding round. The startup's platform takes in the data required to fuel AI algorithms that give clinicians insights to improve patient care.

The healthcare lawyer and former GC weighs in on pitfalls for healthcare startups and how executives can find success.

Healthcare startups focused on solutions for payers and hospitals as well as consumers and employers will compete in the Pitch Perfect contest at MedCity INVEST May 22-24 in Chicago. Register today!

Retail clinic claims volumes have shot up by 200% in the past five years, according to a new report. The research argued that retailers are beginning to seriously compete with the traditional healthcare system when it comes to the primary care market — growth in retail clinic claims have greatly outpaced claims growth for urgent care centers, emergency departments and physician practices.

By selling U.S. rights to Yutiq, EyePoint Pharmaceuticals gets $75 million cash to support its drug pipeline. The company’s lead product candidate is in mid-stage development for wet age-related macular degeneration and non-proliferative diabetic retinopathy.